Family Legacy Inc’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.17M | Sell |
6,711
-491
| -7% | -$498K | 1.85% | 14 |
|
|
2025
Q4 | $7.74M | Sell |
7,202
-59
| -0.8% | -$56.4K | 2.32% | 6 |
|
|
2025
Q3 | $5.54M | Buy |
7,261
+45
| +0.6% | +$33.5K | 1.69% | 19 |
|
|
2025
Q2 | $5.63M | Sell |
7,216
-29
| -0.4% | -$22.5K | 1.83% | 15 |
|
|
2025
Q1 | $5.98M | Sell |
7,245
-670
| -8% | -$558K | 2.05% | 7 |
|
|
2024
Q4 | $6.23M | Buy |
7,915
+217
| +3% | +$180K | 2.11% | 6 |
|
|
2024
Q3 | $6.82M | Sell |
7,698
-83
| -1% | -$74.6K | 2.27% | 3 |
|
|
2024
Q2 | $7.04M | Sell |
7,781
-678
| -8% | -$542K | 2.52% | 3 |
|
|
2024
Q1 | $6.58M | Sell |
8,459
-1,241
| -13% | -$883K | 2.37% | 4 |
|
|
2023
Q4 | $5.65M | Sell |
9,700
-458
| -5% | -$267K | 2.16% | 6 |
|
|
2023
Q3 | $5.46M | Sell |
10,158
-344
| -3% | -$177K | 2.28% | 4 |
|
|
2023
Q2 | $4.93M | Sell |
10,502
-496
| -5% | -$208K | 1.98% | 10 |
|
|
2023
Q1 | $3.78M | Buy |
10,998
+131
| +1% | +$44.2K | 1.62% | 22 |
|
|
2022
Q4 | $3.8M | Sell |
10,867
-173
| -2% | -$61.3K | 1.66% | 16 |
|
|
2022
Q3 | $3.57M | Buy |
11,040
+158
| +1% | +$50.1K | 1.79% | 14 |
|
|
2022
Q2 | $3.52M | Sell |
10,882
-144
| -1% | -$43.2K | 1.67% | 18 |
|
|
2022
Q1 | $3.16M | Sell |
11,026
-628
| -5% | -$162K | 1.32% | 29 |
|
|
2021
Q4 | $3.06M | Buy |
11,654
+80
| +0.7% | +$20.3K | 1.25% | 32 |
|
|
2021
Q3 | $2.71M | Buy |
11,574
+46
| +0.4% | +$11.4K | 1.22% | 36 |
|
|
2021
Q2 | $2.75M | Buy |
11,528
+2
| +0% | +$402 | 1.23% | 35 |
|
|
2021
Q1 | $2.15M | Buy |
11,526
+5
| +0% | +$978 | 1.03% | 45 |
|
|
2020
Q4 | $1.95M | Buy |
11,521
+110
| +1% | +$16.4K | 1% | 42 |
|
|
2020
Q3 | $1.69M | Buy |
11,411
+48
| +0.4% | +$7.43K | 0.96% | 43 |
|
|
2020
Q2 | $1.87M | Sell |
11,363
-109
| -1% | -$16.7K | 1.13% | 39 |
|
|
2020
Q1 | $1.59M | Buy |
11,472
+263
| +2% | +$36.1K | 1.15% | 36 |
|
|
2019
Q4 | $1.5M | Buy |
11,209
+1,330
| +13% | +$154K | 0.85% | 49 |
|
|
2019
Q3 | $1.11M | Buy |
9,879
+2,885
| +41% | +$321K | 0.69% | 56 |
|
|
2019
Q2 | $775K | Buy |
6,994
+501
| +8% | +$59K | 0.61% | 59 |
|
|
2019
Q1 | $826K | Sell |
6,493
-49
| -0.7% | -$5.96K | 0.67% | 57 |
|
|
2018
Q4 | $757K | Buy |
6,542
+435
| +7% | +$48.6K | 0.68% | 55 |
|
|
2018
Q3 | $655K | Buy |
6,107
+70
| +1% | +$7K | 0.53% | 61 |
|
|
2018
Q2 | $515K | Buy |
6,037
+70
| +1% | +$5.75K | 0.44% | 65 |
|
|
2018
Q1 | $462K | Buy |
5,967
+115
| +2% | +$9.26K | 0.43% | 67 |
|
|
2017
Q4 | $494K | Buy |
+5,852
| New | +$498K | 0.45% | 64 |
|
|
2017
Q3 | – | Sell |
-5,852
| Closed | -$482K | – | 76 |
|
|
2017
Q2 | $482K | Hold |
5,852
| – | – | 0.48% | 64 |
|
|
2017
Q1 | $492K | Buy |
+5,852
| New | +$469K | 0.51% | 61 |
|
Other funds holding LLY
VCM
VPM
Family Legacy Inc's LLY Position: Q1 2026 in Review
Family Legacy Inc reduced its Eli Lilly (LLY) stake by 6.8% in Q1 2026, selling an estimated $498K and leaving 6,711 shares worth $6.17M. The position accounts for 1.85% of the portfolio, ranked #14.
Family Legacy Inc first reported a position in LLY in Q1 2017 and has held it in 36 quarters since. The position peaked at $7.74M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Family Legacy Inc held 6,711 shares of Eli Lilly worth $6.17M as of Q1 2026.
- Family Legacy Inc sold 491 Eli Lilly shares in Q1 2026, an estimated $498K.
- Eli Lilly made up 1.85% of Family Legacy Inc's portfolio in Q1 2026, its #14 holding.
- Family Legacy Inc first reported a position in Eli Lilly in Q1 2017 and has held it in 36 quarters since.
- Family Legacy Inc's Eli Lilly position peaked at $7.74M in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Family Legacy Inc's 13F filing for Q1 2026, filed 12 May 2026.